Role of arachidonyl triglycerides within lipid bodies in eicosanoid formation by human polymorphonuclear cells

被引:26
作者
Johnson, MM
Vaughn, B
Triggiani, M
Swan, DD
Fonteh, AN
Chilton, FH
机构
[1] Mayo Clin Jacksonville, Dept Med, Jacksonville, FL 32224 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Div Pulm, Winston Salem, NC 27103 USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol Pharmacol, Winston Salem, NC 27103 USA
[4] Univ Naples Federico II, Sch Med, Dept Internal Med, Div Clin Immunol & Allergy, Naples, Italy
关键词
D O I
10.1165/ajrcmb.21.2.3489
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing evidence suggests that the subcellular and glycerolipid localization of esterified arachidonic acid (AA) is a key factor in regulating its availability to lipases. The goal of the current study was to determine the potential of AA stored in triglycerides (TG) to serve as a substrate for lipases and 5-lipoxygenase during neutrophil (polymorphonuclear leukocytes, PMN) activation. PMN containing high concentrations of AA in TC were generated by culturing PMN in vitro with high concentrations of exogenous AA (eAA) for 12 h. Cellular AA increased 2- and 4-fold in PMNs incubated with 5 and 20 mu M AA, respectively, and this increase was almost exclusively observed in neutral lipids (NL), Further analysis revealed that 88% of the AA in the NL fraction was associated with TG. Subsequent experiments were designed to determine whether this AA in TG could be mobilized and metabolized to eicosanoids during cell activation. TG pools of AA were increased as previously described and then PMN were stimulated with ionophore, A23187. In contrast to the 43-fold increase in TG AA after eAA loading (20 mu M), free AA increased by only 1.9-fold after cell stimulation. Similarly, leukotriene (LT)B-4 production increased only 2-fold after loading TG with large quantities of AA. The magnitude of increase in free AA released and in LTB4 formation was similar to the magnitude of increase in AA mass in phospholipase (PL), suggesting that FL, and not TG, served as the source of released AA and subsequent product generation. To confirm that AA in TG did not serve as a source for eicosanoid production, cellular pools of AA were differentially labeled with C-14]AA and [H-3]AA, and the [H-3]AA-to-[C-14]AA ratio of LTB4 and 20-hydroxyl LTB4 produced during cell stimulation was measured. The [H-3]AA/[C-14]AA ratios of LTs were markedly different from the ratios in TG, thus providing further evidence that AA pools in TG are not a major source of AA for LT generation.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 25 条
[1]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[2]   DIETARY N-3 FATTY-ACID EFFECTS ON NEUTROPHIL LIPID-COMPOSITION AND MEDIATOR PRODUCTION - INFLUENCE OF DURATION AND DOSAGE [J].
CHILTON, FH ;
PATEL, M ;
FONTEH, AN ;
HUBBARD, WC ;
TRIGGIANI, M .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :115-122
[3]   Control of arachidonate levels within inflammatory cells [J].
Chilton, FH ;
Fonteh, AN ;
Surette, ME ;
Triggiani, M ;
Winkler, JD .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1299 (01) :1-15
[4]   STIMULATED PRODUCTION AND NATURAL OCCURRENCE OF 1,2-DIARACHIDONOYLGLYCEROPHOSPHOCHOLINE IN HUMAN-NEUTROPHILS [J].
CHILTON, FH ;
MURPHY, RC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 145 (03) :1126-1133
[5]   PRESENCE OF LIPID DROPLETS AND ABSENCE OF STABLE SUDANOPHILIA IN OSMIUM-FIXED HUMAN LEUKOCYTES [J].
COIMBRA, A ;
LOPESVAZ, A .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1971, 19 (09) :551-+
[6]   DIFFERENCES IN THE BEHAVIOR OF CYTOPLASMIC GRANULES AND LIPID BODIES DURING HUMAN-LUNG MAST-CELL DE-GRANULATION [J].
DVORAK, AM ;
HAMMEL, I ;
SCHULMAN, ES ;
PETERS, SP ;
MACGLASHAN, DW ;
SCHLEIMER, RP ;
NEWBALL, HH ;
PYNE, K ;
DVORAK, HF ;
LICHTENSTEIN, LM ;
GALLI, SJ .
JOURNAL OF CELL BIOLOGY, 1984, 99 (05) :1678-1687
[7]  
DVORAK AM, 1983, J IMMUNOL, V131, P2965
[8]  
DVORAK AM, 1994, INT ARCH ALLERGY IMM, V105, P245
[9]  
DVORAK AM, 1991, BLOOD CELL BIOCH, V4, P27
[10]  
FONTEH AN, 1993, J IMMUNOL, V150, P563